C4 Therapeutics, Inc. (CCCC) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$35.9M

Net Income/Loss (FY2025)

-$105.0M

Total Assets (FY2025)

$359.1M

Total Equity (FY2025)

$256.6M

Cash Flows from Operating Activities (FY2025)

-$98.7M

Source: C4 Therapeutics, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.